MPT: Apixaban Bests Heparin in Cardioversion Treatment

ACC Conference Reporter

ESC 2017 | BARCELONA — Treatment with apixaban (Eliquis) in patients with atrial fibrillation who are scheduled to undergo cardioversion appeared to be superior to treatment with heparin/vitamin K antagonists, researchers reported here. Read More >>>

Keywords: ESC2017, ESC Congress


< Back to Listings